RecruitingNot ApplicableNCT03665831

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

Treatment of Comorbid Depression and Cognitive Impairment in Older Adults With Neurocognitive Disorders Using Deep Transcranial Magnetic Stimulation (dTMS)


Sponsor

Rotman Research Institute at Baycrest

Enrollment

28 participants

Start Date

Oct 23, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, the investigators will be examining the effects of the deep repetitive transcranial magnetic stimulation (rTMS) using the H1 coil in patients over the age of 60 diagnosed with mild to early-moderate Alzheimer's disease (AD) or mild cognitive impairment (MCI) and comorbid Major Depressive Disorder (MDD) who have been unable to tolerate or failed to respond to antidepressant medications. The coil was designed to stimulate deeper regions of the left dorsolateral prefrontal cortex (DLPFC). Based on prior research, the investigators propose that active stimulation with the H1 coil for 4 weeks may result in significant remission rates and will be tolerable and safe.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether deep transcranial magnetic stimulation (Deep TMS) — a non-invasive brain stimulation technique that uses magnetic pulses — can improve both depression and memory/thinking problems in older adults who have both Alzheimer's disease and major depression. **You may be eligible if...** - You have been diagnosed with mild cognitive impairment or dementia due to Alzheimer's disease (with a CDR score of at least 0.5) - You have also been diagnosed with major depression lasting more than 4 weeks but less than 5 years - You have not responded to or could not tolerate antidepressant medications - You are willing to provide informed consent (you or a caregiver) **You may NOT be eligible if...** - You have metal implants in or near your head (e.g., clips, stents, cochlear implants) that are unsafe with magnetic stimulation - You have a history of seizures or epilepsy - You are taking medications that significantly lower the seizure threshold - You have severe dementia or very advanced Alzheimer's - You have other major psychiatric diagnoses - You are currently taking antidepressants that have not been tried long enough Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBrainsway H1-Coil Deep TMS System

Deep Transcranial Magnetic Stimulation (dTMS) is a new form of TMS which allows direct stimulation of deeper neuronal pathways than the standard TMS. The H-coil is a novel dTMS coil designed to allow deeper brain stimulation without a significant increase of electric fields induced in superficial cortical regions. dTMS will be administered daily for 4 consecutive weeks.


Locations(1)

Rotman Research Institute at Baycrest

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03665831


Related Trials